Annual CFO
-$128.22 M
+$51.18 M+28.53%
31 December 2023
Summary:
Fortress Biotech annual cash flow from operations is currently -$128.22 million, with the most recent change of +$51.18 million (+28.53%) on 31 December 2023. During the last 3 years, it has fallen by -$44.54 million (-53.23%). FBIO annual CFO is now -2158.68% below its all-time high of -$5.68 million, reached on 31 December 2010.FBIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$20.06 M
+$1.78 M+8.15%
30 September 2024
Summary:
Fortress Biotech quarterly cash flow from operations is currently -$20.06 million, with the most recent change of +$1.78 million (+8.15%) on 30 September 2024. Over the past year, it has dropped by -$3.28 million (-19.55%). FBIO quarterly CFO is now -1024.38% below its all-time high of -$1.78 million, reached on 31 March 2011.FBIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$102.22 M
-$3.28 M-3.32%
30 September 2024
Summary:
Fortress Biotech TTM cash flow from operations is currently -$102.22 million, with the most recent change of -$3.28 million (-3.32%) on 30 September 2024. Over the past year, it has increased by +$38.91 million (+27.57%). FBIO TTM CFO is now -5629.76% below its all-time high of -$1.78 million, reached on 31 March 2011.FBIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBIO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.5% | -19.6% | +27.6% |
| 3 y3 years | -53.2% | +7.5% | -4.0% |
| 5 y5 years | -29.7% | -23.3% | -11.0% |
FBIO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.2% | +28.5% | -19.6% | +58.1% | -4.0% | +43.0% |
| 5 y | 5 years | -53.2% | +28.5% | -23.3% | +58.1% | -26.8% | +43.0% |
| alltime | all time | -2158.7% | +28.5% | -1024.4% | +58.1% | -5629.8% | +43.0% |
Fortress Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.06 M(-8.1%) | -$102.22 M(+3.3%) |
| June 2024 | - | -$21.84 M(-14.0%) | -$98.94 M(-10.4%) |
| Mar 2024 | - | -$25.39 M(-27.3%) | -$110.39 M(-13.9%) |
| Dec 2023 | -$128.22 M(-28.5%) | -$34.94 M(+108.2%) | -$128.22 M(-9.1%) |
| Sept 2023 | - | -$16.78 M(-49.6%) | -$141.13 M(-15.8%) |
| June 2023 | - | -$33.29 M(-23.0%) | -$167.63 M(-4.6%) |
| Mar 2023 | - | -$43.22 M(-9.7%) | -$175.76 M(-2.0%) |
| Dec 2022 | -$179.40 M(+53.9%) | -$47.84 M(+10.6%) | -$179.40 M(+5.4%) |
| Sept 2022 | - | -$43.27 M(+4.5%) | -$170.25 M(+14.5%) |
| June 2022 | - | -$41.42 M(-11.6%) | -$148.68 M(+4.9%) |
| Mar 2022 | - | -$46.86 M(+21.1%) | -$141.71 M(+21.6%) |
| Dec 2021 | -$116.54 M(+39.3%) | -$38.70 M(+78.4%) | -$116.54 M(+18.5%) |
| Sept 2021 | - | -$21.70 M(-37.0%) | -$98.33 M(-2.2%) |
| June 2021 | - | -$34.46 M(+58.9%) | -$100.53 M(+20.4%) |
| Mar 2021 | - | -$21.69 M(+5.9%) | -$83.48 M(-0.2%) |
| Dec 2020 | -$83.68 M(-11.9%) | -$20.49 M(-14.3%) | -$83.68 M(-5.2%) |
| Sept 2020 | - | -$23.89 M(+37.2%) | -$88.25 M(+9.5%) |
| June 2020 | - | -$17.41 M(-20.5%) | -$80.62 M(-11.9%) |
| Mar 2020 | - | -$21.89 M(-12.6%) | -$91.53 M(-3.6%) |
| Dec 2019 | -$94.96 M(-3.9%) | -$25.05 M(+54.0%) | -$94.96 M(+3.1%) |
| Sept 2019 | - | -$16.26 M(-42.6%) | -$92.07 M(-8.5%) |
| June 2019 | - | -$28.32 M(+11.8%) | -$100.57 M(+4.4%) |
| Mar 2019 | - | -$25.32 M(+14.3%) | -$96.33 M(-2.5%) |
| Dec 2018 | -$98.85 M(+21.6%) | -$22.16 M(-10.5%) | -$98.85 M(+1.3%) |
| Sept 2018 | - | -$24.76 M(+2.8%) | -$97.55 M(-0.3%) |
| June 2018 | - | -$24.08 M(-13.5%) | -$97.87 M(+0.2%) |
| Mar 2018 | - | -$27.84 M(+33.5%) | -$97.67 M(+20.1%) |
| Dec 2017 | -$81.31 M | -$20.86 M(-16.8%) | -$81.31 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$25.09 M(+5.0%) | -$78.41 M(+26.2%) |
| June 2017 | - | -$23.88 M(+108.1%) | -$62.15 M(+36.1%) |
| Mar 2017 | - | -$11.47 M(-36.1%) | -$45.65 M(-0.4%) |
| Dec 2016 | -$45.81 M(+124.8%) | -$17.97 M(+103.7%) | -$45.81 M(+31.3%) |
| Sept 2016 | - | -$8.82 M(+19.5%) | -$34.90 M(+11.4%) |
| June 2016 | - | -$7.38 M(-36.6%) | -$31.32 M(+4.0%) |
| Mar 2016 | - | -$11.64 M(+64.8%) | -$30.11 M(+47.8%) |
| Dec 2015 | -$20.38 M(+24.8%) | -$7.06 M(+34.7%) | -$20.38 M(+21.0%) |
| Sept 2015 | - | -$5.24 M(-15.0%) | -$16.84 M(+17.6%) |
| June 2015 | - | -$6.17 M(+223.8%) | -$14.32 M(+17.7%) |
| Mar 2015 | - | -$1.91 M(-46.0%) | -$12.16 M(-25.5%) |
| Dec 2014 | -$16.33 M(-44.9%) | -$3.53 M(+29.7%) | -$16.33 M(-18.1%) |
| Sept 2014 | - | -$2.72 M(-32.3%) | -$19.94 M(-18.4%) |
| June 2014 | - | -$4.01 M(-33.9%) | -$24.44 M(-13.4%) |
| Mar 2014 | - | -$6.07 M(-14.8%) | -$28.23 M(-4.8%) |
| Dec 2013 | -$29.65 M(+27.8%) | -$7.13 M(-1.2%) | -$29.65 M(+0.1%) |
| Sept 2013 | - | -$7.22 M(-7.5%) | -$29.62 M(+9.5%) |
| June 2013 | - | -$7.80 M(+4.1%) | -$27.06 M(+7.1%) |
| Mar 2013 | - | -$7.49 M(+5.4%) | -$25.26 M(+8.9%) |
| Dec 2012 | -$23.19 M(+111.8%) | -$7.11 M(+52.5%) | -$23.19 M(+17.4%) |
| Sept 2012 | - | -$4.66 M(-22.4%) | -$19.75 M(+9.6%) |
| June 2012 | - | -$6.01 M(+10.7%) | -$18.02 M(+23.5%) |
| Mar 2012 | - | -$5.42 M(+48.2%) | -$14.59 M(+33.2%) |
| Dec 2011 | -$10.95 M(+92.9%) | -$3.66 M(+24.8%) | -$10.95 M(+50.2%) |
| Sept 2011 | - | -$2.93 M(+13.9%) | -$7.29 M(+67.3%) |
| June 2011 | - | -$2.57 M(+44.3%) | -$4.36 M(+144.3%) |
| Mar 2011 | - | -$1.78 M | -$1.78 M |
| Dec 2010 | -$5.68 M | - | - |
FAQ
- What is Fortress Biotech annual cash flow from operations?
- What is the all time high annual CFO for Fortress Biotech?
- What is Fortress Biotech annual CFO year-on-year change?
- What is Fortress Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Fortress Biotech?
- What is Fortress Biotech quarterly CFO year-on-year change?
- What is Fortress Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Fortress Biotech?
- What is Fortress Biotech TTM CFO year-on-year change?
What is Fortress Biotech annual cash flow from operations?
The current annual CFO of FBIO is -$128.22 M
What is the all time high annual CFO for Fortress Biotech?
Fortress Biotech all-time high annual cash flow from operations is -$5.68 M
What is Fortress Biotech annual CFO year-on-year change?
Over the past year, FBIO annual cash flow from operations has changed by +$51.18 M (+28.53%)
What is Fortress Biotech quarterly cash flow from operations?
The current quarterly CFO of FBIO is -$20.06 M
What is the all time high quarterly CFO for Fortress Biotech?
Fortress Biotech all-time high quarterly cash flow from operations is -$1.78 M
What is Fortress Biotech quarterly CFO year-on-year change?
Over the past year, FBIO quarterly cash flow from operations has changed by -$3.28 M (-19.55%)
What is Fortress Biotech TTM cash flow from operations?
The current TTM CFO of FBIO is -$102.22 M
What is the all time high TTM CFO for Fortress Biotech?
Fortress Biotech all-time high TTM cash flow from operations is -$1.78 M
What is Fortress Biotech TTM CFO year-on-year change?
Over the past year, FBIO TTM cash flow from operations has changed by +$38.91 M (+27.57%)